Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript

Cancer

Volumn 77, Issue 1, 1996, Pages 25-29

  Miwa, Takeshi ^a   Watanabe, Akihiko ^a   Yamada, Yukishige ^a   Shino, Yoshihide ^a   Yamada, Takashi ^a   Yamashita, Jun ^a   Matsuda, Masahiko ^a   Nakano, Hiroshige ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

CD44 epithelial variant; CD44 hematopoietic variant; gastric carcinoma; progression

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH CARCINOMA; TUMOR GROWTH;

EID: 0030050053     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19960101)77:1<25::aid-cncr6>3.3.co;2-l     Document Type: Article

References (30)

1. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 1987; 105:983-90.
2. Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 1988; 141:1615-23.
3. Pals ST, Horst E, Scheper RJ, Meijer CJLM. Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol Rev 1989; 108:111-33.
4. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell II. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89:12160-4.
5. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992; 267:4732-9.
6. Screaton GR, Bell MV, Bell JI, Jackson DG. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J Biol Chem 1993; 17:12235-8.
7. Tölg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21:1225-9.
8. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989; 56:1056-62.
9. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10:343-8.
10. Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincaide PW. Monoclonal antibodies to Pgp-1/CD44 block lymph-hematopoiesis in long-term bone marrow culture. J Exp Med 1990; 171:477-88.
11. Huet S, Groux H, Caillou B, Valentin H, Prieur M, Beernard A. CD44 contributes to T cell activation. J Immunol 1987; 143:798-801.
12. MEL-14 Proc Natl Acad Sci USA 1991; 88:7877-81.
13. Arch R, Wirth M, Hofmann M, Ponta H, Matzku S, Herrlich P, et al. Participation in normal immune response of a metastasis-inducing splice variant of CD44. Science 1992; 257:682-5.
14. Naujokas MF, Morin M, Andersen MS, Peterson M, Miller I. The chondroitin sulfate of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 1993; 74:257-68.
15. Brown TA, Bouchard T, John TS, Wayner E, Carter WG. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 1991; 113:207-21.
16. Dougherty GJ, Lansdorp PM, Cooper DL, Humphries RK. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "Homing" receptor expressed by hemopoietic cells. J Exp Med 1991; 174:1-5.
17. Sy MS, Guo YJ, Stamenkovic I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 1991; 174:859-66.
18. Dougherty GJ, Dougherty ST, Eaves CJ, McBride WH. Expression of human CD44R1 enhances the metastatic capacity of murine fibrosarcoma cells. Proc Am Assoc Cancer Res 1992; 33:35 (Abstr 206).
19. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120:227-33.
20. Matsumura Y. Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340:1053-8.
21. Tanabe KK, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993; 341:725-6.
22. Wielenga VJM, Heider KH, Offerhaus GJA, Adolf GR, van den Berg F, Ponta H, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53:4754-6.
23. Guo YJ, Liu G, Wang X, Jin D, Wu M, Ma J, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994; 54:422-6.
24. Heider KH, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993; 53:4197-203.
25. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study 1993. Tokyo: Kanehara & Co. Ltd, 1993.
26. Chomczynski P, Sacchi N. Single-step of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
27. Günther U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
28. Hoffman M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51:5292-7.
29. Seiter S, Arch R, Reber S, Komitowski D, Hoffman M, Ponta H, et al. Prevention of tumor metastasis formation by antivariant CD44. J Exp Med 1993; 177:443-55.
30. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177:897-904.